Survival numbers needed to treat. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Cell Line, Tumor Cells, Cultured Cell Line Tumor Cells, Cultured Neurons Lymph Nodes T-Lymphocytes Macrophages

Organisms8

Mice, Inbred C57BL Mice, Knockout Mice, Inbred BALB C Mice, Transgenic Mice, Nude Mice, SCID Rats, Sprague-Dawley Animals, Newborn

Diseases49

Lung Neoplasms Neoplasm Recurrence, Local Breast Neoplasms Adenocarcinoma Neoplasm Metastasis Liver Neoplasms Brain Neoplasms Recurrence Disease Progression Disease Models, Animal Neoplasms Lymphatic Metastasis Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Carcinoma, Squamous Cell Pancreatic Neoplasms Melanoma Neoplasm Invasiveness Glioblastoma Ovarian Neoplasms Postoperative Complications Carcinoma Carcinoma, Hepatocellular Prostatic Neoplasms Stomach Neoplasms Multiple Myeloma Kidney Neoplasms Bone Neoplasms Glioma Esophageal Neoplasms Skin Neoplasms Kidney Failure, Chronic Heart Arrest Carcinoma, Renal Cell Acute Disease Colonic Neoplasms Head and Neck Neoplasms Leukemia, Myeloid, Acute Sarcoma Rectal Neoplasms Lymphoma, Non-Hodgkin Bile Duct Neoplasms Cholangiocarcinoma Lymphoma, Large B-Cell, Diffuse Osteosarcoma Leukemia, Lymphocytic, Chronic, B-Cell Carcinoma, Small Cell Precursor Cell Lymphoblastic Leukemia-Lymphoma Hodgkin Disease

Chemicals and Drugs56

Antineoplastic Agents Tumor Markers, Biological Cisplatin Doxorubicin Fluorouracil Cyclophosphamide Survival of Motor Neuron 1 Protein Vincristine Antibodies, Monoclonal Proto-Oncogene Proteins RNA, Messenger Immunosuppressive Agents Prednisone Phosphatidylinositol 3-Kinases Etoposide RNA, Small Interfering Deoxycytidine Antimetabolites, Antineoplastic Tumor Suppressor Protein p53 Neoplasm Proteins Protein-Serine-Threonine Kinases Antibodies, Monoclonal, Humanized Methotrexate bcl-X Protein Survival of Motor Neuron 2 Protein Dacarbazine Enzyme Inhibitors Recombinant Proteins Antineoplastic Agents, Alkylating Nerve Growth Factors Paclitaxel Protein Kinase Inhibitors Receptor, erbB-2 DNA-Binding Proteins Carboplatin Vinblastine Cytarabine Transcription Factors Leucovorin Cytokines Caspase 3 Receptor, Epidermal Growth Factor Organoplatinum Compounds Antineoplastic Agents, Phytogenic Taxoids Apoptosis Regulatory Proteins NF-kappa B Bleomycin Vascular Endothelial Growth Factor A Receptors, Estrogen Membrane Proteins Caspases bcl-Associated Death Protein Ki-67 Antigen Tumor Suppressor Proteins Tumor Necrosis Factor-alpha

Analytical, Diagnostic and Therapeutic Techniques and Equipment88

Survival Rate Disease-Free Survival Survival Analysis Treatment Outcome Retrospective Studies Kaplan-Meier Estimate Follow-Up Studies Neoplasm Staging Proportional Hazards Models Antineoplastic Combined Chemotherapy Protocols Combined Modality Therapy Prognosis Multivariate Analysis Prospective Studies Immunohistochemistry Risk Factors Cohort Studies Chemotherapy, Adjuvant Disease Models, Animal Transplantation, Homologous Predictive Value of Tests Registries Drug Administration Schedule Risk Assessment Actuarial Analysis Remission Induction Liver Transplantation Radiotherapy, Adjuvant Kidney Transplantation Life Tables Blotting, Western Randomized Controlled Trials as Topic Reverse Transcriptase Polymerase Chain Reaction Clinical Trials as Topic SEER Program Gene Expression Profiling Models, Biological Analysis of Variance Reoperation Incidence Heart Transplantation Neoadjuvant Therapy Severity of Illness Index Patient Selection Cause of Death Probability Palliative Care Chi-Square Distribution Radiotherapy Dosage Treatment Failure Cardiopulmonary Resuscitation Drug Therapy, Combination Transplantation, Autologous Hepatectomy Neoplasm Grading Salvage Therapy Tumor Burden Regression Analysis Hematopoietic Stem Cell Transplantation Tissue Array Analysis Xenograft Model Antitumor Assays Neoplasm Transplantation Transfection Radiotherapy Oligonucleotide Array Sequence Analysis Bone Marrow Transplantation Stem Cell Transplantation Transplantation, Heterologous Lymph Node Excision Renal Dialysis Clinical Trials, Phase III as Topic In Situ Nick-End Labeling Genetic Therapy Cell Count Immunotherapy Chemoradiotherapy Immunoenzyme Techniques Dose-Response Relationship, Radiation Risk Statistics, Nonparametric Random Allocation Administration, Oral Tomography, X-Ray Computed Skin Transplantation Gene Knockdown Techniques Polymerase Chain Reaction Life Expectancy Chemoembolization, Therapeutic

Phenomena and Processes39

Cell Survival Graft Survival Time Factors Apoptosis Signal Transduction Cell Proliferation Mutation Gene Expression Regulation, Neoplastic Graft Rejection Dose-Response Relationship, Drug Microbial Viability Cell Death Tissue Survival Cell Differentiation Phosphorylation Drug Resistance, Neoplasm Cell Division Probability Longevity Chi-Square Distribution Up-Regulation Phenotype Gene Expression Regulation Transfection Gene Expression Down-Regulation Enzyme Activation Pregnancy RNA Interference Cell Cycle Cell Count Cell Movement Dose-Response Relationship, Radiation Risk Genotype Gene Deletion Radiation Tolerance Oxidative Stress Drug Synergism

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Survival Quality of Life

Humanities1

Quality of Life

Information Science8

Survival Rate Registries Life Tables SEER Program Incidence Cause of Death Molecular Sequence Data Life Expectancy

Named Groups3

Tissue Donors Infant, Newborn Survivors

Health Care39

Survival Rate Disease-Free Survival Survival Analysis Treatment Outcome Retrospective Studies Kaplan-Meier Estimate Follow-Up Studies Proportional Hazards Models Multivariate Analysis Prospective Studies Risk Factors Cohort Studies Age Factors Predictive Value of Tests Registries Risk Assessment Actuarial Analysis Life Tables Randomized Controlled Trials as Topic Clinical Trials as Topic SEER Program Refusal to Treat Analysis of Variance Incidence Severity of Illness Index Patient Selection Cause of Death Probability Palliative Care Chi-Square Distribution Treatment Failure Regression Analysis Sex Factors Clinical Trials, Phase III as Topic Dose-Response Relationship, Radiation Risk Statistics, Nonparametric Random Allocation Life Expectancy

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Survival Rate Cell Survival Disease-Free Survival Survival Survival Analysis Graft Survival Treatment Outcome Retrospective Studies Time Factors Kaplan-Meier Estimate Follow-Up Studies Neoplasm Staging Proportional Hazards Models Apoptosis Antineoplastic Combined Chemotherapy Protocols Combined Modality Therapy Prognosis Antineoplastic Agents Lung Neoplasms Multivariate Analysis Signal Transduction Neoplasm Recurrence, Local Breast Neoplasms Cell Line, Tumor Prospective Studies Immunohistochemistry Tumor Markers, Biological Risk Factors Adenocarcinoma Mice, Inbred C57BL Neoplasm Metastasis Cohort Studies Cells, Cultured Liver Neoplasms Brain Neoplasms Chemotherapy, Adjuvant Recurrence Disease Progression Cisplatin Cell Proliferation Disease Models, Animal Neoplasms Lymphatic Metastasis Age Factors Transplantation, Homologous Predictive Value of Tests Doxorubicin Registries Fluorouracil Mutation Carcinoma, Non-Small-Cell Lung Drug Administration Schedule Cyclophosphamide Colorectal Neoplasms Carcinoma, Squamous Cell Gene Expression Regulation, Neoplastic Risk Assessment Mice, Knockout Graft Rejection Dose-Response Relationship, Drug Survival of Motor Neuron 1 Protein Actuarial Analysis Vincristine Mice, Inbred BALB C Pancreatic Neoplasms Remission Induction Liver Transplantation Microbial Viability Radiotherapy, Adjuvant Melanoma Neoplasm Invasiveness Kidney Transplantation Life Tables Glioblastoma Ovarian Neoplasms Postoperative Complications Cell Death Carcinoma Blotting, Western Antibodies, Monoclonal Proto-Oncogene Proteins Cell Line RNA, Messenger Randomized Controlled Trials as Topic Carcinoma, Hepatocellular Reverse Transcriptase Polymerase Chain Reaction Tissue Survival Clinical Trials as Topic Cell Differentiation United States SEER Program Gene Expression Profiling Immunosuppressive Agents Prostatic Neoplasms Phosphorylation Stomach Neoplasms Prednisone Models, Biological Refusal to Treat Analysis of Variance

No FAQ available that match "survival numbers needed to treat"